High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition

Rheumatology

Volumn 48, Issue 3, 2009, Pages 258-261

  Berger, C T ^a   Wolbers, M ^b   Meyer, P ^c   Daikeler, T ^a   Hess, C ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Acetylsalicylic acid; Giant cell arteritis; Ischaemia; Platelets; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; PREDNISONE;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD VESSEL BIOPSY; BLURRED VISION; CELL SIZE; CEREBROVASCULAR ACCIDENT; CLAUDICATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; EYE DISEASE; FEMALE; FEVER; GIANT CELL ARTERITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; TRANSITIONAL BLINDNESS; VISUAL IMPAIRMENT;

AGED; AGED, 80 AND OVER; ASPIRIN; BLOOD PLATELETS; BRAIN ISCHEMIA; CELL SIZE; FEMALE; GIANT CELL ARTERITIS; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; OPTIC NEUROPATHY, ISCHEMIC; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; RETROSPECTIVE STUDIES; STROKE; VISION DISORDERS;

EID: 61349084973     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken480     Document Type: Article

References (18)

1. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002;347:261-71.
2. Cid MC, Font C, Oristrell J et al. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum 1998;41:26-32.
3. Gonzalez-Gay MA, Blanco R, Rodriguez-Valverde V et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum 1998;41:1497-504.
4. Liozon E, Herrmann F, Ly K et al. Risk factors for visual loss in giant cell (temporal) arteritis: A prospective study of 174 patients. Am J Med 2001;111:211-7.
5. Nesher G, Berkun Y, Mates M et al. Risk factors for cranial ischemic complications in giant cell arteritis. Medicine 2004;83:114-22.
6. Salvarani C, Cimino L, Macchioni P et al. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis. Arthritis Rheum 2005;53:293-7.
7. Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J. Giant cell arteritis: Disease patterns of clinical presentation in a series of 240 patients. Medicine 2005;84:269-76.
8. Chatelain D, Duhaut P, Schmidt J et al. Pathological features of temporal arteries in patients with giant cell arteritis presenting with permanent visual loss. Ann Rheum Dis 2008;58:2565-73.
9. Makkuni D, Bharadwaj A, Wolfe K, Payne S, Hutchings A, Dasgupta B. Is intimal hyperplasia a marker of neuro-ophthalmic complications of giant cell arteritis? Rheumatology 2008;47:488-90.
10. Lee MS, Smith SD, Galor A, Hoffman GS. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis Rheum 2006;54:3306-9.
11. Salvarani C, Casali B, Farnetti E et al. PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 2007;56:3502-8.
12. Lopez-Diaz MJ, Llorca J, Gonzalez-Juanatey C, Pena-Sagredo JL, Martin J, Gonzalez-Gay MA. The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis. Semin Arthritis Rheum 2008;38:116-23.
13. Gonzalez-Gay MA, Pineiro A, Gomez-Gigirey A et al. Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine 2004;83:342-7.
14. O'Malley T, Langhorne P, Elton RA, Stewart C. Platelet size in stroke patients. Stroke 1995;26:995-9.
15. Hunder GG, Bloch DA, Michel BA et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
16. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2006. http://cran.rproject.org (10 December 2008, date last accessed).
17. Van Buuren S, Oudshoorn C. Multivariate imputation by chained equations. MICE V1.0 user's manual. 2000, http://web.inter.nl.net/users/ S.van.Buuren/mi/hmtl/mice.htm (10 December 2008, date last accessed).
18. De Keyser J, De Klippel N, Ebinger G. Thrombocytosis and ischaemic complications in giant cell arteritis. Br Med J 1991;303:825.